Frequency of the transthyretin Val30Met mutation in the northern Swedish population

被引:21
|
作者
Olsson, Malin [1 ]
Jonasson, Jenni [2 ]
Cederquist, Kristina [2 ]
Suhr, Ole B. [1 ]
机构
[1] Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden
[2] Umea Univ Hosp, Dept Clin Genet Lab Med, S-90185 Umea, Sweden
来源
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2014年 / 21卷 / 01期
关键词
Amyloidosis-hereditary-neuropathic; ATTRV30M (p.ATTRV50M); frequency; genotyping; mutation; transthyretin; TTR c.(Val50Met); POLYNEUROPATHY;
D O I
10.3109/13506129.2013.860027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By genotyping a large number of samples from the Northern Sweden Health and Disease Study cohort, a carrier frequency could be determined for the Skelleftea and Lycksele populations. A previous study of the amyloidogenic transthyretin mutation TTRV30M in Northern Sweden's endemic area has shown a large variation in carrier frequency and penetrance of the trait within the area. However, the estimations have been based on a small sample size within the different regions in the area and therefore, the wide variation in TTRV30M carrier frequency observed between the Lycksele and Skelleftea populations are uncertain. Based on a total of 3460 samples, the estimated overall carrier frequency in the two regions was 1.82% with a carrier frequency in the Skelleftea and Lycksele population of 1.63% and 2.02%, respectively. Thus, the previously reported extremely high frequency in the Lycksele region compared to that of the Skelleftea region could not be substantiated. However, it does not change the previous finding of a surprisingly higher carrier frequency in the population from endemic area of Northern Sweden compared to that reported from endemic areas in Portugal.
引用
收藏
页码:18 / 20
页数:3
相关论文
共 50 条
  • [31] Presence of val30Met and val122ile mutations in a patient with hereditary amyloidosis
    da Silva-Batista, Jemima A.
    Marques Jr, Wilson
    Oliveira, Mayala Thayrine de J. S.
    Lins, Lucas Vergne C.
    Galvao, Adilson Junior P.
    Miguel, Diego Santana Chaves G.
    Machado-Costa, Marcela Camara
    JOURNAL OF HUMAN GENETICS, 2020, 65 (08) : 711 - 713
  • [32] Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation
    Liu, Jinping
    Lan, Jie
    Zhao, Peng
    Zheng, Fang
    Song, Jingjing
    Zhang, Peilan
    Sun, Xuguo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (11): : 7795 - 7800
  • [33] Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
    Waddington-Cruz, Marcia
    Wixner, Jonas
    Amass, Leslie
    Kiszko, Jan
    Chapman, Doug
    Ando, Yukio
    NEUROLOGY AND THERAPY, 2021, 10 (02) : 753 - 766
  • [34] Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met)
    Koike, Haruki
    Nakamura, Tomohiko
    Nishi, Ryoji
    Ikeda, Shohei
    Kawagashira, Yuichi
    Iijima, Masahiro
    Yasuda, Takeshi
    Mukai, Eiichiro
    Date, Yukari
    Shiomi, Kazutaka
    Nakazato, Masamitsu
    Katsuno, Masahisa
    Sobue, Gen
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 : 24 - 25
  • [35] Phenotypes Associated With the Val122Ile, Leu58His, and Late-Onset Val30Met Variants in Patients With Hereditary Transthyretin Amyloidosis
    Zampino, Serena
    Sheikh, Farooq H.
    Vaishnav, Joban
    Judge, Daniel
    Pan, Baohan
    Daniel, Amrita
    Brown, Emily
    Ebenezer, Gigi
    Polydefkis, Michael
    NEUROLOGY, 2023, 100 (19) : E2036 - E2044
  • [36] Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation
    Koike, Haruki
    Nakamura, Tomohiko
    Nishi, Ryoji
    Ikeda, Shohei
    Kawagashira, Yuichi
    Iijima, Masahiro
    Katsuno, Masahisa
    Sobue, Gen
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 : 13 - 14
  • [37] Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis
    Hirakawa, Kyoko
    Takashio, Seiji
    Marume, Kyohei
    Yamamoto, Masahiro
    Hanatani, Shinsuke
    Yamamoto, Eiichiro
    Sakamoto, Kenji
    Izumiya, Yasuhiro
    Kaikita, Koichi
    Oda, Seitaro
    Utsunomiya, Daisuke
    Shiraishi, Shinya
    Ueda, Mitsuharu
    Yamashita, Taro
    Yamashita, Yasuyuki
    Ando, Yukio
    Tsujita, Kenichi
    ESC HEART FAILURE, 2019, 6 (01): : 122 - 130
  • [38] Response: concerning "late early and late onset" ATTR Val30Met patients
    Suhr, Ole B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 (04): : 250 - 250
  • [39] Japanese monozygotic twins with familial amyloidotic polyneuropathy (FAP) (ATTR Val30Met)
    Ando, Y
    Ohtsu, Y
    Terazaki, H
    Kibayashi, K
    Nakamura, M
    Ando, E
    Matsunaga, N
    Obayashi, K
    Uchino, M
    Ando, M
    Tsunenari, S
    AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 2000, 7 (02): : 133 - 136
  • [40] A novel compound heterozygote (FAP ATTR Arg104His ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels
    Terazaki, H
    Ando, Y
    Misumi, S
    Nakamura, M
    Ando, E
    Matsunaga, N
    Shoji, S
    Okuyama, M
    Ideta, H
    Nakagawa, K
    Ishizaki, T
    Ando, M
    Saraiva, MJM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (02) : 365 - 370